AI-generated summary
The authors randomly assigned patients with severe non-neovascular age-related macular degeneration to a wearable LED red-light device or a placebo device with the lights off, over 10 short sessions. They report that mean microperimetry sensitivity and central visual function improved in the treated group, while anatomical measures did not differ between groups.
- Who or what was studied
- Patients with severe non-neovascular age-related macular degeneration with relative sparing of the foveal region
- Limits stated in the abstract
- The abstract does not report the number of participants, and it gives no detail on sample size or follow-up beyond short-term sessions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Age-related macular degeneration, Irradiance, Light-emitting diode, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.